FengHe Fund Management’s Legend Biotech LEGN Stock Holding History

FengHe Fund Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-475,263	Closed	-$26.1M	–	19
2022 Q2	$26.1M	Sell	475,263 -522,451	-52%	-$22.1M	10.25%	4
2022 Q1	$36.3M	Buy	997,714 +437,208	+78%	+$17.3M	13.28%	3
2021 Q4	$26.1M	Sell	560,506 -4,300	-0.8%	-$218K	18.14%	2
2021 Q3	$28.6M	Buy	564,806 +38,734	+7%	+$1.61M	25.01%	2
2021 Q2	$21.6M	Buy	526,072 +153,083	+41%	+$5.2M	11.36%	3
2021 Q1	$10.8M	Buy	372,989 +103,917	+39%	+$2.83M	8.53%	3
2020 Q4	$7.58M	Buy	+269,072	New	+$7.75M	5.58%	3

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

FengHe Fund Management's LEGN Position: Q3 2022 in Review

FengHe Fund Management sold out of Legend Biotech (LEGN) in Q3 2022, closing a stake of 475,263 shares — an estimated $26.1M sold.

FengHe Fund Management first reported a position in LEGN in Q4 2020 and held it in 7 quarters. The position peaked at $36.3M in Q1 2022. 159 funds tracked by Wall St. Rank hold LEGN as of Q3 2022.

FengHe Fund Management reported no remaining Legend Biotech position as of Q3 2022 after selling out during the quarter.
FengHe Fund Management sold 475,263 Legend Biotech shares in Q3 2022, an estimated $26.1M.
FengHe Fund Management first reported a position in Legend Biotech in Q4 2020 and held it in 7 quarters.
FengHe Fund Management's Legend Biotech position peaked at $36.3M in Q1 2022.
159 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2022.

Based on FengHe Fund Management's 13F filing for Q3 2022, filed 4 Nov 2022.